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Abstract
Background: Micronutrients polyphenols, tocopherols and phytosterols in rapeseed exert potential benefit to
cardiovascular system, but most of these micronutrients are removed by the refining process. The aim of this study
was to determine the effect of rapeseed oil fortified with these micronutrients on the atherosclerosis risk factors in
rats fed a high-fat diet.
Methods: The rodent diet contained 20% fat whose source was refined rapeseed oil (RRO) or fortified refined
rapeseed oil with low, middle and high quantities of these micronutrients (L-, M- and H-FRRO). Forty male SD rats
were divided into four groups. One group received RRO diet and other groups received L-, M- and H-FRRO diet for
10 weeks.
Results: Micronutrients supplementation significantly increased plasma antioxidant defense capacities, as evaluated
by the significant elevation in the activities of GPx, CAT and SOD as well as the level of GSH, and the significant
decline in lipid peroxidation. These micronutrients also reduced the plasma contents of TG, TC and LDL-C and
increased the ratio of HDL-C/LDL-C. In addition, in parallel with the enhancement of these micronutrients, plasma
levels of IL-6 and CRP declined remarkably.
Conclusion: Rapeseed oil fortified with micronutrients polyphenols, tocopherols and phytosterols may contribute
to prevent atherogenesis by ameliorating plasma oxidative stress, lipid profile and inflammation.
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Inflammation
1. Introduction
Cardiovascular disease (CVD) is the largest cause of
premature death in most developed and developing
countries and it is also an increasingly important
source of disability and contributes in large part to the
escalating costs of health care. Atherosclerosis is the
most common pathologic process underlying CVD. It
is clear that several risk factors such as oxidant stress
[1], lipid abnormalities [2] as well as chronic inflam-
mation [3] have been correlated to both the initiation
and the progression of atherosclerosis and subsequent
CVD.
Rapeseed oil is one of the major and cheapest vegeta-
ble oils for human diet in china and many other coun-
tries. This kind of plant oil has the lowest concentration
of saturated fatty acids in all commonly consumed oils
and high level of monounsaturated fatty acids [4]. In
addition, it is also the major source of linoleic acid and
a-linolenic acid, and it is, so far, the closest to the opti-
mum to meet the basic requirements of essential fatty
acids in the body [5]. A lot of studies have shown that
rapeseed oil can reduce serum total cholesterol (TC)
and/or low-density lipoprotein cholesterol (LDL-C)
when fed in place of saturated fatty acids [6-8], which
means that rapeseed oil possesses significant health ben-
efits in reducing atherosclerosis risk. In addition to tria-
cylglycerols, rapeseed oil also contains many
micronutrients such as tocopherols, phytosterols and
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impart health benefits or desirable physiological effects.
For example, these micronutrients are the most impor-
tant natural antioxidants which act as free radical sca-
vengers or complexers of prooxidant metals, and the
various bioavailable antioxidants present in rapeseed oil
work in concert to upgrade the complex antioxidant
network which increase antioxidant capacity higher than
that provided by each separate compound [9-11]. Phy-
tosterols have been reported to exert hypocholesterole-
mic effect by inhibiting cholesterol absorption [12].
Studies also point out an independent effect of pheno-
lics improving plasma lipid profiles [13,14]. In addition,
all these compounds are also believed to have antiin-
flammatory effects [14-16]. All these beneficial effects of
these micronutrients might participate in preventing the
initiation and development of atherosclerosis. However,
although most unwanted components are removed, the
traditional processing technology currently used in the
world (extraction and refining) markedly decreases the
content of these micronutrients, which will have an
adverse effect on the protection of cardiovascular
system.
In order to increase the levels of these micronutrients
in rapeseed oil, some improving processing technologies
[17] which can preserve the content of these micronutri-
ents in rapeseed oil have been researched, and artificially
adding micronutrients to r e f i n e do i lm a yb ea n o t h e r
simple and expedient method. The present study tried
to investigate that whether rapeseed oil fortified with
micronutrients (polyphenols, tocopherols and phytoster-
ols) can reduce atherosclerosis risk factors in rats fed a
high-fat diet.
2. Materials and methods
2.1 Fortification of rapeseed oil with micronutrients
The refined rapeseed oil was obtained from Hulunbuir
Jinjiao Bio-chemical Ltd, and its levels of tocopherols,
phytosterols and phenolic compounds were analyzed
and shown in table 1. Tocopherols (wuhan yuancheng,
china), fat-soluble polyphenols (pulimeidi biotech, china)
and plant sterol esters (Vegapure 95E
®,C o g n i sG m b H ,
Germany) were used as the fortificants in this study.
The rapeseed oil was fortified with low, middle and high
contents of these fortificants and the contents of these
micronutrients in the fortified oil were also shown in
table 1.
2.2 Animals and diets
Forty male Sprague-Dawley rats, initially weighing
150-170 g, were purchased from Sino-British Sippr/BK
(Shanghai, China). The rats were housed individually
and maintained at a controlled ambient temperature
( 2 4±1° C )u n d e rd i u r n a lc o nditions (light-dark:
08:00-20:00) with access to laboratory chow and tap
water ad libitum. After the rats were acclimated for 1
week, animals were randomly divided into four groups
of 10 animals each, consisting of the refined rapeseed
oil group (RRO), fortified refined rapeseed oil with
low, middle and high contents of these fortificants (L-,
M-, and H-FRRO) groups. The high-fat diet contained
20% casein, 35% maize starch, 15% glucose, 5% cellu-
lose, 3.5% mineral mixture (AIN-93M), 1% vitamin
mixture (AIN-93M), 0.2% choline bitartrate, 0.3% DL-
methionine and 20% fat. The fat in the diet was pro-
vided by different rapeseed oils mentioned above. All
animals were weighed twice a week and food intake
was measured weekly. The animals were cared for in
accordance with the Guiding Principles in the Care
and Use of Animals. The experiment was approved by
the Oil Crops Research Institute Council on Animal
Care Committee, Chinese Academy of Agricultural
Sciences.
2.3 Blood processing
After 10 weeks of treatment, rats were fasted for 16
hours and then killed under anaesthesia, blood was col-
lected in the presence of sodium heparin from the heart
immediately. Blood samples were centrifuged at 1500 g
(10 min, 4°C) and the plasma was stored at −80°C until
analysis.
2.4 Plasma lipids analysis
The plasma concentrations of triglyeride (TG), TC,
LDL-C and high-density lipoprotein cholesterol (HDL-
C) were measured with commercial kits (Zhongsheng
Beikong Biotech Company, China).
2.5 Assay of plasma antioxidant capacity and lipid
peroxidation
2.5.1 Determination of glutathione peroxidase (GPx)
GPx activity was determined by the use of commercial
kit (Nanjing Jiancheng Bioengineering Institute, China)
based on the method of Sazuka et al. [18]. Briefly,
plasma mixed with GSH and hydrogen peroxide was
incubated at 37 °C for 3 min, followed by the addition
of 10% trichloro acetic acid. After centrifugation, the
supernatant was collected and mixed with disodium
hydrogen phosphate and 5,5,-dithiobis(2-nitro-benzoic
acid). The absorbance was recorded at 412 nm. The
unit of GPx activity was expressed as micromoles GSH
oxidation per 5 minute per 0.1 millilitre plasma.
Table 1 Micronutrients contents in different rapeseed oils
mg/kg oil RRO L-FRRO M-FRRO H-FRRO
polyphenols 36.7 200 400 800
phytosterols 9035.8 10000 20000 40000
tocopherols 143.8 500 1000 2000
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CAT activity was estimated according to the method of
Goth [19] with slight modification. Briefly, 50 μlo f
sample was mixed with 50 μl of substrate (6.5 μM
hydrogen peroxide in phosphate buffer) for 60 s, then
100 μl of 32.4 mM ammonium molybdate solution
were added and absorbance change was measured at
405 nm. One unit of the enzyme was defined as milli-
moles of hydrogen peroxide degraded per minute per
millilitre plasma.
2.5.3 Determination of superoxide dismutase (SOD)
SOD activity was estimated basing on the method of
Kono [20] with slight modification. Briefly, the reac-
tion was initiated by mixing an appropriate plasma
with 0.5 mM hypoxanthine, 0.5 mM hydroxylamine
and 0.01 U xanthine oxidase in the buffer, containing
of 104 mM potassium phosphate, 78 mM sodium
borate and 0.025 mM EDTA (PH 7.0) at 37 °C for 30
m i ni nar e a c t i o nv o l u m eo f1 0 0μl. The reaction was
terminated by adding 0.2 ml of 16% (v/v) acetic acid
solution containing 2.6 mM sulfanilic acid and 38.6
μM naphthyl ethylenediamine and the absorbance at
550 nm was recorded for the calculation of SOD
activity. Under the conditions, one nitroso unit of
enzyme activity was calculated as that inhibiting 50%
of the oxidation of hydroxylamine without an enzyme
source.
2.5.4 Determination of reduced glutathione (GSH)
The GSH content was estimated by the use of commer-
cial kit (Nanjing Jiancheng Bioengineering Institute,
China) based on the method of Moron et al. [21].
Briefly, the plasma was precipitated with 50% trichloro
acetic acid and then centrifuged at 1000 g for 5 min.
The reaction mixture containing 50 μl of supernatant,
200 μl of 0.2 M Tris-EDTA buffer (PH 8.9) and 10 μlo f
0.01 M 5,5,-dithiobis(2-nitro-benzoic acid) was kept at
room temperature for 5 min, and then measured at 412
nm. The GSH concentration was calculated using a
GSH standard curve.
2.5.5 Determination of total antioxidant capability (T-AOC)
The T-AOC was assayed with commercial kits (Nanjing
Jiancheng Bioengineering Institute, China).
2.5.6 Determination of thiobarbituric acid reactive
substances (TBARS)
TBARS level was measured by the method of Buege and
Aust [22]. Briefly, the plasma was incubated reagent
containing 0.375% thiobarbituric acid, 15% trichloro
acetic acid, 0.25 M HCl, and 6.8 mM 2,6-di-tert-butyl-4-
methylphenol for 60 min in a boiling water bath. The
mixture was centrifuged at 3000 rpm for 15 min, the
absorbance of the supernatant was recorded at 532 nm
by using 1,1,3,3-tetraethoxypropane as standard. The
lipid peroxidation was expressed as TBARS in nano-
moles per millilitre plasma.
2.6. Assay of plasma inflammatory markers
Plasma interleukin 6 (IL-6) and C-reactive protein (CRP)
levels were determined using rat IL-6 ELISA kit
(eBioscience San Diego, CA) and rat CRP ELISA kit
(eBioscience San Diego, CA), respectively. All the condi-
tions and procedures were consistent with the instruc-
tions of these kits.
2.6 Statistical analyses
Values are presented as mean ± SD. The data were ana-
lyzed by one-way ANOVA, followed by the Fisher PLSD
post hoc test if the overall differences were significant
(p< 0.05). All statistical analyses were performed using
SPSS 13.0 statistical software (SPSS Inc., Chicago, IL)
and a difference was considered significant when p <
0.05.
3. Results
3.1. Food intake and food utilization rate
There were no remarkable differences in food intake or
food utilization rate were observed among all groups
throughout the experiment. The average food utilization
rate (%) was 15.31 ± 2.35, 15.83 ± 3.22, 14.85 ± 2.40,
15.04 ± 2.20 for RRO group, L-, M-, and H-FRRO
groups, respectively.
3.2. Plasma antioxidative capacity and lipid peroxidation
As can be seen in Figure 1 and 2, significant increases in
the activities of plasma antioxidant enzymes GPx and
C A Ti nM -a n dH - F R R Og r o u p sa n dS O Di nH - F R R O
group were observed when compared with the RRO
group. Animals in M- and H-FRRO groups revealed sig-
nificantly higher plasma GSH levels than their counter-
parts in RRO group. As the overall antioxidative
capacity, plasma T-AOC in M- and H-FRRO groups
was significantly higher than that in RRO group. In
addition, when plasma TBARS were examined as the
marker of lipid peroxidation, animals in all FRRO
groups revealed marked lower TBARS levels than that
in RRO group.
3.3. Plasma lipids
As shown in Figure 3 and 4, there were marked decline
in the levels of both plasma TG and TC in M- and H-
FRRO groups when compared with those in RRO group.
Because animals in all FRRO groups showed signifi-
cantly lower LDL-C levels than rats in RRO group and
HDL-C levels were similar in all groups, all FRRO
groups were therefore had the significantly higher ratios
of HDL to LDL cholesterol than RRO group.
3.4. Plasma inflammatory
The effect of FRRO on plasma IL-6 and CRP levels are
shown in Figure 5. The FRRO decreased the plasma IL-
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Figure 1 Effects of rapeseed oil fortified with micronutrients
(polyphenols, tocopherols and phytosterols) on the activities
of antioxidant enzymes (GPx, CAT and SOD) in plasma of rats
fed a high-fat diet. RRO: the refined rapeseed oil group; L-. M- and
H- FRRO: fortified refined rapeseed oil with low, middle and high
contents of micronutrients groups. Bars represent the mean ± SD
from 10 animals in each group. ** p < 0.01 compared to the RRO
group.
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Figure 2 Effects of rapeseed oil fortified with micronutrients
(polyphenols, tocopherols and phytosterols) on the levels of
GSH, T-AOC and contents of TBARS in plasma of rats fed a
high-fat diet. RRO: the refined rapeseed oil group; L-. M- and H-
FRRO: fortified refined rapeseed oil with low, middle and high
contents of micronutrients groups. Bars represent the mean ± SD
from 10 animals in each group. * p < 0.05 and ** p < 0.01
compared to the RRO group.
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Page 4 of 86 and CRP levels in a dose-dependent manner, and both
plasma IL-6 and CRP levels in rats of M- and H-FRRO
groups were significantly lower than that of RRO group.
4. Discussion
As one of the commonly consumed vegetable oils in the
world, rapeseed oil has the potential to meet consumers’
dietary needs because it has the lowest concentration of
saturated fatty acids, a very favorable ratio of linoleic acid
to a-linolenic acid and the predominantly of monounsatu-
rated fatty acids. The optimum fatty acid composition of
this oil can exert a hypo chotesterolsemic effect [6-8,23,24]
when fed in place of higher saturated fatty acids-containing
fats and thus benefits the protection of CVD.
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Figure 3 Effects of rapeseed oil fortified with micronutrients
(polyphenols, tocopherols and phytosterols) on TG, TC and
HDL-C in plasma of rats fed a high-fat diet. RRO: the refined
rapeseed oil group; L-. M- and H- FRRO: fortified refined rapeseed
oil with low, middle and high contents of micronutrients groups.
Bars represent the mean ± SD from 10 animals in each group. * p <
0.05 and ** p < 0.01 compared to the RRO group.
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Figure 4 Effects of rapeseed oil fortified with micronutrients
(polyphenols, tocopherols and phytosterols) on plasma LDL-C
and on the ratios of plasma HDL-C/LDL-C of rats fed a high-fat
diet. RRO: the refined rapeseed oil group; L-. M- and H- FRRO:
fortified refined rapeseed oil with low, middle and high contents of
micronutrients groups. Bars represent the mean ± SD from 10
animals in each group. * p < 0.05 and ** p < 0.01 compared to the
RRO group.
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taken in the study of many micronutrients contained in
rapeseed because of their excellent bioactivity. These
micronutrients include phytosterols and various antioxi-
dants such as polyphenols, coenzyme Q and tocopher-
ols, and the joint actions of all these bioactive molecules
may contribute to prevent the risk of atherosclerosis.
Unfortunately, most of these micronutrients are lost
during the oilseed oil refining. The present study exam-
ined the effect of reducing atherosclerosis risk factors by
artificially adding micronutrients (polyphenols, toco-
pherols and phytosterols) to refined rapeseed oil.
The imbalance between the cellular free radical forma-
tion and the antioxidant defense leads to oxidative
stress. The relative excessive production of free radicals
can attack many different cellular components, including
lipids, proteins and DNA, which initiates the processes
of atherogenesis through cell dysfunction [25]. In fact,
oxidative stress is the unifying mechanism for many
CVD risk factors [26]. For example, free radicals med-
iate many signaling pathways which underlie vascular
inflammation in atherogenesis [27]. However, the dele-
terious effects of oxidative stress can be prevented by
enzymatic and non-enzymatic antioxidant defense
mechanism. In mammals, the most important antioxi-
dant enzymes include SOD which converts superoxide
to hydrogen peroxide, GPx and CAT which are respon-
sible for converting hydrogen peroxide to water [28]. As
a very important non-enzymatic antioxidant, GSH can
react directly with free radical or act an electron donor
in the reduction of peroxides catalyzed by GPx [29]. In
addition to scavenge free radicals directly, supplement
of these micronutrients in the present study also signifi-
cantly elevated plasma activities of SOD, CAT and GPx
as well as level of GSH, which led to the remarkable
increase of T-AOC and were thus favorable to attenuate
oxidative stress. As a result, plasma lipid peroxidation
levels were significantly decreased with the supplement
of these micronutrients. In accord with these findings,
these micronutrients naturally abundant in rapeseed oil
have been reported to increase antioxidant status and
lipid peroxidation in plasma [17] as well as in brain [30].
Hyperlipemia is also well known to be closely linked
to arteriosclerosis and other cardiovascular disease. It
has been reported that rapeseed oil possessed hypolipi-
demic properties [7,31] and which could be due to its
optimum fatty acid composition. In line with expecta-
tions, the further reduction in plasma TG, TC and LDL-
C were observed with the fortification of rapeseed oil
with micronutrients in this study. The micronutrients
phytosterols and polyphenols were both responsible for
these beneficial changes. Many studies have shown that
intake of phytosterols is effective at lowering plasma TC
and LDL-C. Phytosterols have a similar chemical struc-
ture with cholesterol but themselves are absorbed only
in trace amounts [32], thus they inhibit cholesterol
absorption including recirculating endogenous biliary
cholesterol which is a key step in cholesterol elimination
[ 3 2 ] .T h e s em e a n tt h a ta l t h o u g hr o d e n td i e tc o n t a i n e d
little cholesterol in this study, inhibition of intestinal cho-
lesterol absorption was still the main mechanism respon-
sible for the cholesterol-lowering effect of phytosterols.
Besides, the hypolipidaemic effect of the phytosterols
were also associated with the down-regulation of hepatic
acyl CoA:cholesterol acytransferase activity [24] and the
increasing LDL receptor expression [33]. Polyphenols
have been shown to reduce plasma TG, TC and LDL-C
by altering hepatic triglyceride assembly and secretion,
cholesterol absorption and the processing of lipoproteins
in plasma [14]. Although these micronutrients did not
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Figure 5 Effects of rapeseed oil fortified with micronutrients
(polyphenols, tocopherols and phytosterols) on the level of IL-
6 and CRP in plasma of rats fed a high-fat diet. RRO: the refined
rapeseed oil group; L-. M- and H- FRRO: fortified refined rapeseed
oil with low, middle and high contents of micronutrients groups.
Bars represent the mean ± SD from 10 animals in each group. * p <
0.05 and ** p < 0.01 compared to the RRO group.
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increase in the ratio of HDL to LDL cholesterol still
meant that FRRO had a significant protective effect with
regard to atherosclerosis. It should be pointed out that
although rat was used as a model for lipid metabolism in
our investigation and others [17,34], the plasma lipid and
lipoprotein profile in this species are very different from
human, and therefore further experimentation is needed
to verify the beneficial effects on lipid metabolism of
human subjects.
Recent advances in both the basic and clinical science
have recognized the critical role of inflammation in all
stages of atherosclerosis [35-37]. Various proinflamma-
tory risk factors (oxidized LDL, infectious agents, etc)
can trigger the production of proinflammatory cytokines
which contribute to development and progression of
atherosclerosis. IL-6 and CRP are two of the most
important proinflammatory cytokines, and both of
which have been served as inflammatory markers for
evaluation of atherosclerotic risk [38-40]. In parallel
with the enhancement of these micronutrients in the
present study, plasma levels of both IL-6 and CRP
declined remarkably, which meant that FRRO was able
to improve inflammation status. Each ingredient of
these micronutrients has been suggested to play a role
in inhibition of inflammatory cytokine production
[14-16]. For example, both polyphenols and tocopherols
have been shown to retard LDL oxidation through their
antioxidant property [15,41] and inhibit the synthesis of
leukotriene B4 (LTB4) [42,43]. Polyphenols can also
exert the anti-inflammatory effect by inactivating
STAT1 and NF-B [44].
In conclusion, rapeseed oil fortified with tocopherols,
polyphenols and phytosterols has the ability to ameliorate
oxidative stress, lipid profile and inflammation of plasma.
These results suggested that the rapeseed oil fortified
with these micronutrients might contribute to prevent
atherogenesis and then reduce the incidence of CVD.
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